PCSA
Processa Pharmaceuticals
$2.59
−$0.01 (−0.38%)Jul 27, 2026
Key metrics
The numbers that frame PCSA today
- Market cap
- $7.12M
- P/E (TTM)
- -0.5
- EV / FCF
- -0.4
- ROIC
- 14,525.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.67
- 52wk High
- $14.24
Growth
Revenue and earnings trend for PCSA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PCSA
Is Processa Pharmaceuticals a good buy?
No. Processa Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Processa Pharmaceuticals is selling at a very high price.
What is the market capitalization of PCSA?
Processa Pharmaceuticals's market capitalization is $7.12M.
What is the P/E ratio for PCSA stock?
Processa Pharmaceuticals's current P/E ratio is -0.5.
What is the 52-week high for PCSA stock?
The 52-week high for Processa Pharmaceuticals is $14.24. The current close of $2.59 is 81.8% below that high.
What is the 52-week low for PCSA stock?
The 52-week low for Processa Pharmaceuticals is $1.67. The current close of $2.59 is 55.1% above that low.
Does PCSA stock pay dividends?
Processa Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PCSA?
Processa Pharmaceuticals's Debt / Equity ratio is 0.